Holen Sie sich die Stockscreener-App
2.48
0.00%
0.00
Schlusskurs vom Vortag:
$2.48
Offen:
$2.48
24-Stunden-Volumen:
711.13K
Relative Volume:
1.84
Marktkapitalisierung:
$130.13M
Einnahmen:
$21.05M
Nettoeinkommen (Verlust:
$-89.22M
KGV:
-1.3855
EPS:
-1.79
Netto-Cashflow:
$-64.50M
1W Leistung:
+12.22%
1M Leistung:
+55.00%
6M Leistung:
+72.22%
1J Leistung:
-52.85%
1-Tages-Spanne:
$2.28
$2.5699
1-Wochen-Bereich:
$2.07
$2.57
52-Wochen-Spanne:
$1.02
$6.225
Tscan Therapeutics Inc Stock (TCRX) Company Profile
Firmenname
Tscan Therapeutics Inc
Sektor
Branche
Telefon
857-399-9500
Adresse
830 WINTER STREET, WALTHAM
Vergleichen Sie TCRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TCRX
Tscan Therapeutics Inc
|
2.48 | 140.74M | 21.05M | -89.22M | -64.50M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-16 | Eingeleitet | BTIG Research | Buy |
| 2024-05-13 | Eingeleitet | Needham | Buy |
| 2023-06-22 | Eingeleitet | Wedbush | Outperform |
Tscan Therapeutics Inc Aktie (TCRX) Neueste Nachrichten
Will TScan Therapeutics Inc. stock continue dividend increasesJuly 2025 Technicals & Free Weekly Watchlist of Top Performers - Trung tâm Dự báo KTTV quốc gia
How TScan Therapeutics Inc. stock performs in high volatility marketsLong Setup & Accurate Technical Buy Alerts - newser.com
2 Overlooked Stocks to Snap Up in 2025 - Yahoo Finance
Quantitative breakdown of TScan Therapeutics Inc. recent moveJuly 2025 Catalysts & Reliable Price Action Trade Plans - newser.com
How TScan Therapeutics Inc. stock reacts to global recession fearsExit Point & Low Drawdown Trading Strategies - newser.com
TScan Therapeutics Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
What MACD and RSI say about TScan Therapeutics Inc.July 2025 Action & AI Enhanced Trading Alerts - newser.com
TScan Therapeutics Inc. stock daily chart insightsJuly 2025 PreEarnings & Verified Technical Trade Signals - newser.com
How to forecast TScan Therapeutics Inc. trends using time series2025 Big Picture & Safe Entry Zone Identification - newser.com
Short interest data insights for TScan Therapeutics Inc.July 2025 Trends & Long-Term Capital Growth Strategies - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for TScan Therapeutics (NASDAQ:TCRX) - MarketBeat
Will TScan Therapeutics Inc. stock maintain momentum in 2025Portfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com
What the charts say about TScan Therapeutics Inc. today2025 Winners & Losers & AI Driven Stock Reports - newser.com
Is TScan Therapeutics Inc a good long term investmentSwing Trading Ideas & Fast Growing Capital Growth - earlytimes.in
Goldman Sachs Group Inc. Buys 9,676 Shares of TScan Therapeutics, Inc. $TCRX - Defense World
Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):